metformin has been researched along with peptide yy in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashcroft, A; Bloom, SR; Dovey, TM; Eccleston, D; English, PJ; Ghatei, MA; Halford, JC; Harrison, J; Patterson, M; Wilding, JP | 1 |
| Al-Zaman, Y; Aylwin, S | 1 |
| Batterham, RL; Conway, GS; Tsilchorozidou, T | 1 |
| Aaboe, K; Deacon, CF; Holst, JJ; Knop, FK; Krarup, T; Madsbad, S; Vilsbøll, T | 1 |
| Apseloff, G; Atiee, G; Bush, MA; Collins, DA; Corsino, L; Feldman, PL; Gillmor, D; McMullen, SL; Morrow, L; Nunez, DJ | 1 |
| Baker, D; Brown, JR; Miller, S; Napolitano, A; Nicholls, AW; Nunez, DJ; Rajpal, D; Spivak, A; Thomas, E; Van Horn, S | 1 |
| Baron, A; Burns, C; Buse, JB; DeFronzo, RA; Fineman, M; Kim, T; Skare, S | 1 |
| de Fontgalland, D; Hollington, P; Keating, DJ; Martin, AM; Rabbitt, P; Sun, EW; Wattchow, DA; Young, RL | 1 |
1 review(s) available for metformin and peptide yy
| Article | Year |
|---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
5 trial(s) available for metformin and peptide yy
| Article | Year |
|---|---|
Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS).
Topics: Adult; Fasting; Female; Humans; Metformin; Peptide YY; Polycystic Ovary Syndrome; Waist Circumference; Weight Loss | 2008 |
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Administration Schedule; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Metformin; Middle Aged; Peptide YY; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2010 |
Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.
Topics: Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Male; Mesylates; Metformin; Middle Aged; Oxadiazoles; Peptide YY; Prognosis; Pyrazines; Receptors, G-Protein-Coupled; Sitagliptin Phosphate; Triazoles | 2014 |
Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.
Topics: Adolescent; Adult; Aged; Bile Acids and Salts; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Intestinal Mucosa; Intestines; Male; Metformin; Microbiota; Middle Aged; Peptide YY | 2014 |
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.
Topics: Adult; Blood Glucose; Cross-Over Studies; Fasting; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Peptide YY; Postprandial Period | 2016 |
2 other study(ies) available for metformin and peptide yy
| Article | Year |
|---|---|
Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes.
Topics: Adult; Appetite; Diabetes Mellitus, Type 2; Energy Metabolism; Female; Ghrelin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Osmolar Concentration; Peptide Hormones; Peptide YY; Postprandial Period; Satiety Response; Thermogenesis | 2007 |
Metformin Triggers PYY Secretion in Human Gut Mucosa.
Topics: Adult; Aged; AMP-Activated Protein Kinases; Colon; Diabetes Mellitus, Type 2; Enteroendocrine Cells; Equilibrative Nucleoside Transport Proteins; Female; Humans; Hypoglycemic Agents; Ileum; Intestinal Mucosa; Male; Metformin; Middle Aged; Peptide YY; Serotonin Plasma Membrane Transport Proteins; Weight Loss | 2019 |